Navigation Links
Questcor Pharmaceuticals Announces Preliminary Operating Metrics for Third Quarter 2011
Date:9/28/2011

ANAHEIM, Calif., Sept. 28, 2011 /PRNewswire/ -- Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR) today announced preliminary operating metrics for its third quarter ending September 30, 2011. The Company announced the estimated metrics in conjunction with the Jeffries Global Healthcare Conference in London, where Don M. Bailey, President and Chief Executive Officer of Questcor, presented on Wednesday, September 28, 2011, at 8:00 a.m. BT, 3:00 a.m. ET.  To listen to the audio web cast of the presentation, please visit www.questcor.com.  The replay will be available for 90 days after the event.

For the quarter ending September 30, 2011, the Company provided the following preliminary estimated operating metrics:

  • Based on internal Company data through September 26, 2011:
    • New, paid prescriptions of the Company's principal drug, H.P. Acthar® Gel (Acthar), for the treatment of exacerbations of multiple sclerosis (MS) during the full third quarter are expected to exceed 850, up over 160% from the year ago period.
    • New, paid prescriptions for nephrotic syndrome (NS) are expected to exceed 55.  
    • New, paid prescriptions for infantile spasms (IS) are expected to exceed 105.
  • Vials of Acthar, shipped during the quarter are expected to exceed 2,750, up over 45% from the year ago period.

During the third quarter, the Company has not repurchased any of its common stock. Prior repurchases have used over $78 million since this effort began in 2008.  As of September 26, 2011, Questcor had 62.7 million shares of common stock outstanding, with 4.3 million shares remaining under its common stock repurchase program.

As of September 26, 2011, Questcor's cash, cash equivalents and short-term
'/>"/>

SOURCE Questcor Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Questcor Pharmaceuticals to Present at the Jefferies Global Healthcare Conference on September 28, 2011
2. Questcor Provides Updated New Paid Prescription Trends
3. UPDATING and ADDING: Questcor Pharmaceuticals to Present at Upcoming Investor Conferences in September
4. Questcor Pharmaceuticals to Present at the Canaccord Genuity Growth Conference on August 11, 2011
5. Questcor to Report Second Quarter 2011 Earnings and Conduct Conference Call on July 26, 2011
6. Questcor Proxy Proposals All Approved at 2011 Shareholder Meeting
7. Questcor Discusses ISS Proxy Recommendations; Provides Business Update
8. Questcor to Report First Quarter 2011 Earnings and Conduct Conference Call on April 26, 2011
9. Questcor Pharmaceuticals Announces Preliminary Operating Metrics for First Quarter 2011
10. Questcor Pharmaceuticals to Present at the Needham Healthcare Conference
11. Questcor Pharmaceuticals to Present at the Barclays Capital Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... 22, 2014 The steady decline of ... to previously rep-friendly specialties, according to the spring ... consulting firm ZS Associates.      AccessMonitor™ ... pharmaceutical sales teams. The report examines how often ... the pharmaceutical sales reps who visit their offices. ...
(Date:7/22/2014)... 2014  UL (Underwriters Laboratories), a global safety ... and Drug Administration (FDA) has recognized two UL ... devices incorporating lithium or nickel-based batteries. The two ... and Commercial Batteries, and UL 1642 - Standard ... standards are standards recognized by the FDA for ...
(Date:7/22/2014)... Texas , July 22, 2014 Quantum Materials Corporation ... and Mr. John Heaton to the Board of Directors. ... Dr. Ghassan Jabbour , QMC Chief Science Officer and Board ... Michael Wong of Rice University and Mr. Tomio Gotoh ... . " Quantum Materials welcomes two ...
Breaking Medicine Technology:Even traditionally rep-friendly specialists will see fewer pharmaceutical sales reps this year, according to ZS Associates 2Even traditionally rep-friendly specialists will see fewer pharmaceutical sales reps this year, according to ZS Associates 3Even traditionally rep-friendly specialists will see fewer pharmaceutical sales reps this year, according to ZS Associates 4Even traditionally rep-friendly specialists will see fewer pharmaceutical sales reps this year, according to ZS Associates 5Two UL Battery Safety Standards Are now FDA Recognized Consensus Standards for Medical Devices 2Quantum Materials Announces New Outside Directors and Adds Scientific Advisory Board 2Quantum Materials Announces New Outside Directors and Adds Scientific Advisory Board 3Quantum Materials Announces New Outside Directors and Adds Scientific Advisory Board 4
... , Feb. 18 R-Squared, an industry ... alliance with IMS Health Inc., to help pharmaceutical and ... state transparency and marketing disclosure laws, known as "aggregate ... state-of-the-art SpendTracker® compliance application platform will be deployed to ...
... , , FRANKLIN, Mass. , ... Bulletin Board: ECTE), a company developing the needle-free Symphony™ ... monitoring (tCGM) system and the Prelude™ SkinPrep System for ... made a significant advance in the product design of ...
Cached Medicine Technology:R-Squared Forms Strategic Relationship with IMS Health 2Echo Therapeutics Announces Significant Product Development Milestone: The Completion of Next Generation Electronic Components for Its Revolutionary, Patented Symphony(TM) tCGM System 2Echo Therapeutics Announces Significant Product Development Milestone: The Completion of Next Generation Electronic Components for Its Revolutionary, Patented Symphony(TM) tCGM System 3
(Date:7/22/2014)... Roanoke, VA (PRWEB) July 22, 2014 ... as a young child. While most kids outgrow ... Tonelson did not. He is among the three million ... can range from mild to severe. Throughout his youth, ... attending in-school speech sessions and visits with private speech-and-language ...
(Date:7/22/2014)... 2014 BESLER Consulting, a leading ... for hospitals, is pleased to offer a complimentary ... to assist hospitals with analyzing their 2015 QualityNet ... on July 21 allow hospitals to validate their ... However, the data contained in these reports can ...
(Date:7/22/2014)... 2014 Kirby Lester, LLC, the leading ... includes streamlined functionality to perform a trackable double-count for ... Since a double-count of controlled medications is required, the ... quickly perform a second count of any tablet or ... of the second count up to 10 years. This ...
(Date:7/22/2014)... Hill, South Carolina (PRWEB) July 22, 2014 ... weight loss solution managed to lose 20 pounds. Unfortunately, the ... shaky and nauseated for the duration of her time using ... ‘manic’. One woman experienced heart flutters and insomnia as a ... woman experienced a heart attack at the age of 37 ...
(Date:7/22/2014)... 22, 2014 Ronald S. Weaver, ... Inglewood, Calif., today announced a heart transplant patient with ... Counterpulsation (EECP) therapy at Global Cardio Care Centers and ... , The patient, a 55-year-old Hispanic male, also ... Life Program, a nutrition and exercise lifestyle program in ...
Breaking Medicine News(10 mins):Health News:New Steps in the “Ballet of Speech” Create Life-Changing Possibilities for People Who Stutter 2Health News:New Steps in the “Ballet of Speech” Create Life-Changing Possibilities for People Who Stutter 3Health News:New Steps in the “Ballet of Speech” Create Life-Changing Possibilities for People Who Stutter 4Health News:Complimentary Re-admissions Analytics Tool Available From BESLER Consulting 2Health News:Kirby Lester KL1Plus Pharmacy Automation Perfect for Double-Counting & Tracking Prescriptions from Any Pharmacy Robot 2Health News:SlimPlate System Urge Women to Shun Controversial Weight Loss Pills for Healthier Methods Like Portion Control 2Health News:Ronald S. Weaver, MD, Owner of Global Cardio Care Centers, Announces EECP Treatment Success for Cardiomyopathy Patient Who Needed Heart Transplant 2Health News:Ronald S. Weaver, MD, Owner of Global Cardio Care Centers, Announces EECP Treatment Success for Cardiomyopathy Patient Who Needed Heart Transplant 3
... ... professionals are turning to BurrellesLuce for valuable advice on making optimal use of Twitter and ... ... public relations practice, many PR professionals are turning to BurrellesLuce for valuable advice ...
... LINO LAKES, Minn., Aug. 26 Despite ... construction firms have been recognized by Minnesota Laborers-Employers Cooperation and ... 2008. , , Begun in 2007, the ... performance and proactive approach of Skilled Construction Union Laborers and ...
... , , WASHINGTON, Aug. ... who was a champion for vulnerable people throughout his life and a ... the midst of America,s great discussion of health care reform, Kennedy was ... We hope that Congress will honor his memory with the completion of ...
... arsenic from the body, according to a new study that ... the potentially toxic substance. The study found that some people ... the diet. Others store arsenic in their bodies, where it ... application of new methods for studying arsenic, is scheduled for ...
... , , WILMINGTON, ... comparative effectiveness study performed by HealthCore, Inc. in its August ... better clinical outcomes with oral controllers than inhaled corticosteroids. , ... requested the comparative effectiveness study to help ensure that its ...
... , JERICHO, N.Y., Aug. 26 Optimum ... New York metropolitan area businesses, today announced that Medical ... in Long Island, has selected Optimum Lightpath as its ... Optimum Lightpath,s 100% fiber Ethernet connection, Medical Arts Radiology ...
Cached Medicine News:Health News:PR Professionals Making Good Use of Social Media With Help From Twitter Webinars Run by BurrellesLuce 2Health News:PR Professionals Making Good Use of Social Media With Help From Twitter Webinars Run by BurrellesLuce 3Health News:Twenty-Two Regional Construction Firms Recognized for Their Commitment to Worker Safety 2Health News:Comparative Effectiveness Research Study in Mayo Clinic Proceedings Demonstrated Asthma Patients Had Better Overall Results with Oral Controllers than Inhaled Products 2Health News:Comparative Effectiveness Research Study in Mayo Clinic Proceedings Demonstrated Asthma Patients Had Better Overall Results with Oral Controllers than Inhaled Products 3Health News:Comparative Effectiveness Research Study in Mayo Clinic Proceedings Demonstrated Asthma Patients Had Better Overall Results with Oral Controllers than Inhaled Products 4Health News:Medical Arts Radiology Chooses Optimum Lightpath to Speed Anytime, Anywhere Access to Patient Data and Communications 2Health News:Medical Arts Radiology Chooses Optimum Lightpath to Speed Anytime, Anywhere Access to Patient Data and Communications 3
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: